These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 25195111)

  • 21. [The future of radiation oncology: technology, ethical considerations and economical aspects].
    Coucke P
    Rev Med Liege; 2010 Apr; 65(4):186-90. PubMed ID: 20499820
    [TBL] [Abstract][Full Text] [Related]  

  • 22. International patterns of practice in palliative radiotherapy for painful bone metastases: evidence-based practice?
    Fairchild A; Barnes E; Ghosh S; Ben-Josef E; Roos D; Hartsell W; Holt T; Wu J; Janjan N; Chow E
    Int J Radiat Oncol Biol Phys; 2009 Dec; 75(5):1501-10. PubMed ID: 19464820
    [TBL] [Abstract][Full Text] [Related]  

  • 23. IAEA support to radiotherapy dosimetry.
    van der Merwe D; Christaki K
    Acta Oncol; 2020 May; 59(5):493-494. PubMed ID: 32056484
    [No Abstract]   [Full Text] [Related]  

  • 24. Dose painting and theragnostic imaging: towards the prescription, planning and delivery of biologically targeted dose distributions in external beam radiation oncology.
    Bentzen SM
    Cancer Treat Res; 2008; 139():41-62. PubMed ID: 18236711
    [No Abstract]   [Full Text] [Related]  

  • 25. [What is the level of evidence of new techniques in prostate cancer radiotherapy?].
    Khadige M; Peiffert D; Supiot S
    Cancer Radiother; 2014 Oct; 18(5-6):501-8. PubMed ID: 25192625
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A strategy to objectively evaluate the necessity of correcting detected target deviations in image guided radiotherapy.
    Yue NJ; Kim S; Jabbour S; Narra V; Haffty BG
    Med Phys; 2007 Nov; 34(11):4340-7. PubMed ID: 18072499
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Research ethics: French regulations and applications in radiation oncology].
    Haaser T; Berdaï D; Trouette R; Dupin C; Marty S; L'Azou B; Berger V; Saux MC
    Cancer Radiother; 2020 Jul; 24(4):306-315. PubMed ID: 32499188
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Applicability of randomized trials in radiation oncology to standard clinical practice.
    Apisarnthanarax S; Swisher-McClure S; Chiu WK; Kimple RJ; Harris SL; Morris DE; Tepper JE
    Cancer; 2013 Aug; 119(16):3092-9. PubMed ID: 23674290
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Anniversary paper: A sampling of novel technologies and the role of medical physicists in radiation oncology.
    Balter S; Balter JM
    Med Phys; 2008 Dec; 35(12):5641-52. PubMed ID: 19175121
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Should positive phase III clinical trial data be required before proton beam therapy is more widely adopted? No.
    Suit H; Kooy H; Trofimov A; Farr J; Munzenrider J; DeLaney T; Loeffler J; Clasie B; Safai S; Paganetti H
    Radiother Oncol; 2008 Feb; 86(2):148-53. PubMed ID: 18237800
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Prostate cancer: what treatment techniques for which tumors? Ethical and methodological issues].
    de Crevoisier R; Castelli J; Guérif S; Pommier P; Créhange G; Chauvet B; Lagrange JL
    Cancer Radiother; 2014 Oct; 18(5-6):369-78. PubMed ID: 25199865
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Recommendations for the treatment of children with radiotherapy in low- and middle-income countries (LMIC): A position paper from the Pediatric Radiation Oncology Society (PROS-LMIC) and Pediatric Oncology in Developing Countries (PODC) working groups of the International Society of Pediatric Oncology (SIOP).
    Parkes J; Hess C; Burger H; Anacak Y; Ahern V; Howard SC; Elhassan M; Ahmed S; Ghalibafian M; Abbasi AN; Qureshi BM; Zaghloul M; Zubizarreta E; Bey P; Davidson A; Bouffet E; Esiashvili N
    Pediatr Blood Cancer; 2017 Dec; 64 Suppl 5():. PubMed ID: 29297617
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [French organization of paediatric radiation treatment: Results of a survey conducted by the radiotherapy Committee of the French Society of Paediatric Cancers (SFCE)].
    Demoor-Goldschmidt C; Claude L; Carrie C; Bolle S; Helfre S; Alapetite C; Jouin A; Padovani L; Ducassou A; Vigneron C; Le Prisé É; Huchet A; Stefan D; Kerr C; Nguyen TD; Truc G; Chapet S; Bondiau PY; Coche B; Muracciole X; Laprie A; Noël G; Leseur J; Habrand JL; Potet H; Ruffier A; Supiot S; Mahé MA; Bernier V
    Cancer Radiother; 2016 Jul; 20(5):395-9. PubMed ID: 27421622
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Altered fractionation in radiotherapy: from radiobiological rationale to therapeutic gain.
    Marcu LG
    Cancer Treat Rev; 2010 Dec; 36(8):606-14. PubMed ID: 20494524
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Place of proton radiotherapy in future radiotherapy practice.
    Zips D; Baumann M
    Semin Radiat Oncol; 2013 Apr; 23(2):149-53. PubMed ID: 23473693
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Implementing new technology in radiation oncology: The French agency for nuclear safety (ASN) report].
    Lartigau ÉF; Lisbona A; Isambert A; Cadot P; Derreumaux S; Dupuis O; Gérard JP; Ledu D; Mahé MA; Marchesi V; Mazurier J; De Oliveira A; Phare O; Aubert B;
    Cancer Radiother; 2015 Oct; 19(6-7):616-20. PubMed ID: 26278991
    [TBL] [Abstract][Full Text] [Related]  

  • 37. RadioTransNet: Preclinical research network coordinated at the SFRO and SFPM.
    Maingon P; Marchesi V; Azria D; Balosso J; Deutsch É; Cohen Jonathan-Moyal É; Giraud P; Bayart É
    Cancer Radiother; 2022; 26(1-2):108-115. PubMed ID: 34862132
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical trials in molecular radiotherapy-Tribulations and Triumphs Report of the NCRI CTRad meeting held at the Lift Islington, 8 June 2018.
    Falzone N; Gregory R; Aldridge M; Terry SY; Flux G
    Br J Radiol; 2019 Aug; 92(1100):20190117. PubMed ID: 30982344
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Phase I's, photons, and philosophies: new tactics for exploratory clinical trials of concurrent chemoradiation.
    Machtay M
    J Clin Oncol; 2004 Jan; 22(2):214-6. PubMed ID: 14665615
    [No Abstract]   [Full Text] [Related]  

  • 40. Evaluation of novel radiotherapy technologies: what evidence is needed to assess their clinical and cost effectiveness, and how should we get it?
    van Loon J; Grutters J; Macbeth F
    Lancet Oncol; 2012 Apr; 13(4):e169-77. PubMed ID: 22469127
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.